Molfino N[au] - Search Results

Year	Number of Results
1990	1
1991	2
1992	6
1993	2
1994	4
1996	3
1997	1
1998	1
1999	1
2000	1
2002	1
2004	4
2005	1
2006	2
2007	3
2008	1
2009	1
2010	7
2011	4
2012	5
2013	5
2014	3
2015	2
2016	1
2020	1
2021	3

1

Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia.

Laviolette M, Gossage DL, Gauvreau G, Leigh R, Olivenstein R, Katial R, Busse WW, Wenzel S, Wu Y, Datta V, Kolbeck R, Molfino NA. Laviolette M, et al. Among authors: molfino na. J Allergy Clin Immunol. 2013 Nov;132(5):1086-1096.e5. doi: 10.1016/j.jaci.2013.05.020. Epub 2013 Jul 16. J Allergy Clin Immunol. 2013. PMID: 23866823 Free PMC article. Clinical Trial.

2

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study.

Castro M, Wenzel SE, Bleecker ER, Pizzichini E, Kuna P, Busse WW, Gossage DL, Ward CK, Wu Y, Wang B, Khatry DB, van der Merwe R, Kolbeck R, Molfino NA, Raible DG. Castro M, et al. Among authors: molfino na. Lancet Respir Med. 2014 Nov;2(11):879-890. doi: 10.1016/S2213-2600(14)70201-2. Epub 2014 Oct 8. Lancet Respir Med. 2014. PMID: 25306557 Clinical Trial.

3

Near-fatal asthma.

Molfino NA, Slutsky AS. Molfino NA, et al. Eur Respir J. 1994 May;7(5):981-90. Eur Respir J. 1994. PMID: 8050557 Free article. Review.

4

Genetics of COPD.

Molfino NA. Molfino NA. Chest. 2004 May;125(5):1929-40. doi: 10.1378/chest.125.5.1929. Chest. 2004. PMID: 15136409 Review.

5

Targeting of eosinophils in asthma.

Molfino NA. Molfino NA. Expert Opin Biol Ther. 2012 Jul;12(7):807-9. doi: 10.1517/14712598.2012.674938. Epub 2012 Apr 16. Expert Opin Biol Ther. 2012. PMID: 22500988

6

Real-world evidence: Patient views on asthma in respiratory specialist clinics in America.

Oppenheimer J, Slade DJ, Hahn BA, Zografos L, Gilsenan A, Richardson D, McSorley D, Lima R, Molfino NA, Averell CM. Oppenheimer J, et al. Among authors: molfino na. Ann Allergy Asthma Immunol. 2021 Apr;126(4):385-393.e2. doi: 10.1016/j.anai.2020.12.015. Epub 2020 Dec 31. Ann Allergy Asthma Immunol. 2021. PMID: 33387616 Free article.

7

Recent therapeutic breakthroughs in respiratory medicine.

Molfino NA. Molfino NA. Expert Rev Respir Med. 2013 Aug;7(4):331-3. doi: 10.1586/17476348.2013.814388. Expert Rev Respir Med. 2013. PMID: 23964623 No abstract available.

8

Biology of the interleukin-9 pathway and its therapeutic potential for the treatment of asthma.

Oh CK, Raible D, Geba GP, Molfino NA. Oh CK, et al. Among authors: molfino na. Inflamm Allergy Drug Targets. 2011 Jun;10(3):180-6. doi: 10.2174/187152811795564073. Inflamm Allergy Drug Targets. 2011. PMID: 21428906 Review.

9

Challenge models to assess new therapies in chronic obstructive pulmonary disease.

van der Merwe R, Molfino NA. van der Merwe R, et al. Among authors: molfino na. Int J Chron Obstruct Pulmon Dis. 2012;7:597-605. doi: 10.2147/COPD.S30664. Epub 2012 Sep 13. Int J Chron Obstruct Pulmon Dis. 2012. PMID: 23055710 Free PMC article. Review.

10

Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma.

Oh CK, Geba GP, Molfino N. Oh CK, et al. Among authors: molfino n. Eur Respir Rev. 2010 Mar;19(115):46-54. doi: 10.1183/09059180.00007609. Eur Respir Rev. 2010. PMID: 20956165 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results